Relaquine 35 mg/ml oral gel for horses

Main information

  • Trade name:
  • Relaquine 35 mg/ml oral gel for horses
  • Pharmaceutical form:
  • Oral gel
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Relaquine 35 mg/ml oral gel for horses
    Netherlands
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • Acepromazine
  • Therapeutic area:
  • Horses

Other information

Status

  • Source:
  • HMA - Europe
  • Authorization number:
  • UK/V/0465/001
  • Authorization date:
  • 21-12-2012
  • EU code:
  • UK/V/0465/001
  • Last update:
  • 09-08-2016

Summary of Product characteristics: dosage,interactions,side effects

Revised:May2013

AN:00075/2012

SUMMARYOFPRODUCTCHARACTERISTICS

1. NAMEOFTHEVETERINARYMEDICINALPRODUCT

Relaquine35mg/mlOralGelforHorses DE,FR,NL,UK

Relaquinevet35mg/mlOralGelforHorses SE

2. QUALITATIVEANDQUANTITATIVECOMPOSITION

Perml

Activesubstance

Acepromazine

(asAcepromazinemaleate) 35.00mg

(47.50mg)

Excipients:

Methylparahydroxybenzoate

0.65mg

Propylparahydroxybenzoate

0.35mg

Forthefulllistofexcipients,seeSection6.1.

3. PHARMACEUTICALFORM

Oralgel.

Clearyellowgelfororaladministration.

4. CLINICALPARTICULARS

4.1. Targetspecies

Horse.

4.2. Indicationsforuse,specifyingthetargetspecies

Forsedationofhorses.

4.3. Contraindications

Donotuseincasesofpost-traumaticshockorhypovolaemia.

Donotuseinanimalsinastateofsevereemotionalexcitation.

Donotuseinanimalswithepilepsy.

Donotuseinpregnantorlactatingmares.

Donotuseinanimalswithheartfailure.

Donotuseinanimalswithhaematologicaldisorders/coagulopathies.

Revised:May2013

AN:00075/2012

Donotuseinanimalssufferingfromhypothermia.

Donotuseinthecaseofknownhypersensitivitytotheactivesubstanceorany

oftheexcipientsoftheproduct.

4.4. Specialwarningsforeachtargetspecies

Sedationlastsforapproximatelysixhours,althoughtheactualtimeanddepthof

sedationareverydependentonthestatusoftheindividualanimal.

Increasingthedosageabovethatrecommended resultsinprolongedactionand

sideeffectsbutnogreatersedation.

4.5. Specialprecautionsforuse

i) Specialprecautionsforuseinanimals

Installions,thelowestdoserangeisindicatedtominimiseprolapseofthepenis.

Theproductshouldbeusedwithcautionandwithreduceddosageinthecaseof

cardiacorhepaticdiseaseorindebilitated,hypovolemicoranaemicanimals.

Acepromazinehasnegligibleanalgesiceffects.Painfulactivitiesshouldbe

avoidedwhenhandlingtranquillizedanimals.

Tranquillizedhorsesshouldbekeptinacalmplaceandsensorialstimulishould

beavoidedasfaraspossible.

ii) Specialprecautionstobetakenbythepersonadministeringthemedicinal

producttoanimals

Washhandsandexposedskinthoroughlyafteruse.

Personswithsensitiveskinorincontinuouscontactwiththeproductareadvised

towearimpermeablegloves.

Avoidcontactwitheyes.

Ifaccidentaleyecontactoccurs,flushgentlywithrunningwaterfor15minutes

andseekmedicaladviceifanyirritationpersists.

Incaseofaccidentalingestion,seekmedicaladviceimmediatelyandshowthe

packageleafletorthelabeltothephysician.

4.6. Adversereactions(frequencyandseriousness)

Sinceacepromazinedecreasessympatheticnervoussystemtone,atransient

dropinbloodpressuremayoccurafteradministration.

Inhibitionoftemperatureregulation.

Thefollowingreversiblechangesarepossibleinthehaemogram:

-transientdecreaseinerythrocytecountandhaemoglobinconcentration;

-transientdecreaseinthrombocyteandleukocytecounts.

Becauseitincreasesprolactinsecretion,theadministrationofacepromazine

mayleadtodisturbancesinfertility.

Penileprolapsemayoccurduetotherelaxationoftheretractorpenismuscles.

Retractionofthepenisshouldbevisiblewithintwotothreehours.Ifthisdoes

nottakeplace,itisadvisedtocontactaveterinarysurgeon.Lackofretractionis

ofparticularconcerninbreedingstallions.Acepromazinehascaused

paraphimosissometimesinsequeltopriaprism.

Inrarecasesparadoxicalexcitationreactionscandevelop.

Revised:May2013

AN:00075/2012

ContradictoryclinicalsignsofaggressivenessandgeneralisedCNSstimulation

mayoccur.

Prolapseofthenictitatingmembranehasalsobeencitedasapossibleadverse

effectinhorses.

4.7. Useduringpregnancy,lactationorlay

Acepromazineshouldnotbeusedinpregnantorlactatingmares.

Acepromazinehasthepotentialtoinducehypotensioninnewbornswhen

administeredasapremedicationforcaesareansectioninthemare.

PleaseseealsoSection4.6relatingtodisturbancesinfertility.

4.8. Interactionwithothermedicinalproductsandotherformsofinteraction

Acepromazinepotentiatestheactionofcentrallydepressantdrugs.

Thesimultaneoususeoforganicphosphateestersincreasesthetoxicityof

acepromazine.

Sinceacepromazinedecreasessympatheticnervoussystemtone,itshouldnot

begivenatthesametimeasbloodpressurereducingdrugs.

Antacidsmaycauseadecreaseinthegastrointestinalabsorptionof

acepromazineafteroraladministration.

Opiatesmayenhancethehypotensiveeffectsofacepromazine.

4.9. Amount(s)tobeadministeredandadministrationroute

Administrationroute

Fororaladministration.Placethesyringeintheanimal'smouthandexpelthe

requireddoseintothecheekpouch.Thegelmayalsobemixedwithfood.

Amount(s)tobeadministered

Moderatesedation: 0.15mgacepromazineperkgbodyweight

Dosageguidelines:

Bodyweight

(kg) 200 300 400 450 500 600

Dose(ml) 1.0 1.5 1.5 2.0 2.5 2.5

Theabovedosageinformationisprovidedasaguideline.Thedosemaybe

variedtoadministerbetween0.5and1.5timestheaboverecommendation

dependingonthelevelofsedationrequired,i.e.formildsedation,administer

halftherecommendeddoseandfordeepersedation,administer1½timesthe

recommendeddose.

Becauseofthedifficultyinensuringtheaccuratedeliveryofsmalldoses,the

productshouldonlybeusedinhorsesoflessthan200kgbodyweightin

accordancewithabenefit/riskassessmentbytheresponsibleveterinarian.

Revised:May2013

AN:00075/2012

4.10. Overdose(symptoms,emergencyprocedures,antidotes)(ifnecessary)

Overdosageresultsinanearlieronsetofthesedativesymptomsandina

prolongedeffect.Toxiceffectsareataxia,hypotension,hypothermiaandcentral

nervoussystem(extrapyramidal)effects.

Noradrenaline,butnotadrenaline,canbeusedtocounteractthecardiovascular

effects.

4.11. Withdrawalperiod(s)

Donotuse inhorsesintendedforhumanconsumption.

5. PHARMACOLOGICALPROPERTIES

Therapeuticgroup: NervousSystem

ATCvetcode: QN05AA04

5.1. Pharmacodynamicproperties

Acepromazineisaphenothiazinederivative.Thisgroupofmoleculesbelongsto

theneuroleptics:theydepressthecentralnervoussystemandexertassociated

effectsontheautonomicsystem.Theseeffectsareduetotheirinterference

withdifferentneurotransmitterreceptors(dopaminergic,adrenergic)andtotheir

interferencewithhypothalamicperformance.Thesedativeactivitystartswithin

15to30minutesoftreatmentandlastsfor6-7hours.

Thedesiredeffectsobservedaftertreatmentwithacepromazineincludea

generaltranquillizingeffect,anti-emeticeffectandaslightanti-histaminiceffect.

Thereisnoanalgesicaction.Theneurolepticeffectsarevariablebetween

individualanimals.

5.2. Pharmacokineticproperties

Acepromazineispartlyabsorbedfromthegastrointestinaltract.Plasmaprotein

bindingishighanditisextensivelydistributedthroughoutthebodytissues.

Plasmalevelsareusuallylow.Acepromazineishighlymetabolised,withthe

urineasthemainrouteofexcretion.

6. PHARMACEUTICALPARTICULARS

6.1. Listofexcipients

Methylparahydroxybenzoate(E218)

Propylparahydroxybenzoate

Sodiumacetatetrihydrate

Sodiumcyclamate(E952)

Hydroxyethylcellulose

Glycerol(E422)

Purifiedwater

Revised:May2013

AN:00075/2012

6.2. Incompatibilities

Simultaneousadministration,oradministrationtohorsesrecentlytreatedwith

organophosphatesshouldbeavoided,sincethesemoleculesenhancethetoxic

effectsofacepromazine.

Simultaneoustreatmentwithbloodpressureloweringproductsshouldbe

avoided.

6.3. Shelflife

Shelf-lifeoftheveterinarymedicinal

productaspackagedforsale:

2years

Shelf-lifeafterfirstopeningtheimmediate

packaging:

28days

6.4. Specialprecautionsforstorage

Donotstoreabove25°C.

Protectfromfrost.

Protectfromlight.

Whenthecontainerisbroached(opened)forthefirsttime,usewithin28days.

Afteruse,replacecaponsyringe.Keepthebroachedsyringeintheoriginal

cartonandstoreinadryplace.

6.5. Natureandcompositionofimmediatepackaging

Container: White,high-densitypolyethylenesyringebarrel.

White,low-densitypolyethylenesyringeplunger.

Closure: White,high-densitypolyethylene,push-fitcap.

Fillvolume: 10ml

Dosingdevice: Theproductispresentedinanoraldosingsyringewhich

isgraduatedat1mlintervals.

6.6. Specialprecautionsforthedisposalofunusedveterinarymedicinal

productorwastematerialsderivedfromtheuseofsuchproducts

Anyunusedveterinarymedicinalproductorwastematerialsderivedfromsuch

veterinarymedicinalproductsshouldbedisposedofinaccordancewithlocal

requirements.

Revised:May2013

AN:00075/2012

7. MARKETINGAUTHORISATIONHOLDER

FlorisVeterinaireProduktenBV

Kempenlandstraat33

5626GKVught

TheNetherlands

8. MARKETINGAUTHORISATIONNUMBER

Vm36057/4001

9. DATEOFFIRSTAUTHORISATION

10March2011

10. DATEOFREVISIONOFTHETEXT

May2013

Approved: 24/05/2013

3-11-2018

Janssen Issues Voluntary Nationwide Recall for one lot of ORTHO-NOVUM 1/35 and two lots of ORTHO-NOVUM 7/7/7 Due to Incorrect Veridate Dispenser Instructions

Janssen Issues Voluntary Nationwide Recall for one lot of ORTHO-NOVUM 1/35 and two lots of ORTHO-NOVUM 7/7/7 Due to Incorrect Veridate Dispenser Instructions

Janssen Pharmaceuticals, Inc. has initiated a voluntary recall of one lot of ORTHO-NOVUM 1/35 (norethindrone / ethinyl estradiol) Tablets and two lots of ORTHO-NOVUM 7/7/7 (norethindrone / ethinyl estradiol) Tablets to the pharmacy level. The patient information provided inside affected packages of ORTHO-NOVUM does not include the appropriate instructions for the Veridate dispenser.

FDA - U.S. Food and Drug Administration

7-6-2018

Minister Bruno Bruins (Sport) opent Special Olympics 2018

Minister Bruno Bruins (Sport) opent Special Olympics 2018

Dit weekend worden in de Achterhoek de Special Olympics Nationale Spelen gehouden. Meer dan 2000 sporters met een verstandelijke beperking gaan de strijd aan in 20 takken van sport. Sportminister Bruno Bruins zal de Spelen vrijdagavond officieel openen tijdens een feestelijke ceremonie in Stadion de Vijverberg in Doetinchem. Bruno Bruins: ‘Sporten is gezond en vooral leuk. Ik vind het belangrijk dat iedereen kan sporten en er lol aan beleeft. Dat is ook een belangrijk onderdeel van het sportakkoord dat i...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

There are no news related to this product.